Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment:

David W. Dodick,Peter J. Goadsby,C. Lucas,Rigmor Jensen,Jennifer N. Bardos,James M. Martinez,Chunmei Zhou,Sheena K. Aurora,Jyun Yan Yang,Robert R. Conley,Tina M. Oakes

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment:

2020

David W. Dodick
Peter J. Goadsby
C. Lucas
Rigmor Jensen
Jennifer N. Bardos
James M. Martinez
Chunmei Zhou
Sheena K. Aurora
Jyun Yan Yang
Robert R. Conley
Tina M. Oakes

ObjectiveTo report efficacy and safety of galcanezumab in adults with chronic cluster headache.BackgroundGalcanezumab is a humanized monoclonal antibody that binds to calcitonin gene-related peptid...

Keywords:

double blind
Gastroenterology
Anesthesia
Medicine
Calcitonin gene-related peptide
Monoclonal antibody
Placebo-controlled study
Internal medicine
Cluster headache
Calcitonin
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations